We are live on ! Find out more
EHC

Everett Harris & Co Portfolio holdings

AUM $7.77B
1-Year Est. Return 9.43%
This Fund
S&P 500
This Quarter Est. Return
+11.55%
1 Year Est. Return
+9.43%
3 Year Est. Return
+56.4%
5 Year Est. Return
+89.86%
10 Year Est. Return
+333.28%
AUM
$5.66B
AUM Growth
+$536M
Cap. Flow
-$7.04M
Cap. Flow %
-0.12%
Top 10 Hldgs %
54.8%
Holding
261
New
15
Increased
82
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$63.6M
2
HD icon
Home Depot
HD
+$17.7M
3
NVS icon
Novartis
NVS
+$14.9M
4
VZ icon
Verizon
VZ
+$11M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$9.45M

Sector Composition

Rank Sector Weight
1 Technology 20.89%
2 Financials 16.8%
3 Healthcare 15.61%
4 Consumer Staples 12.42%
5 Consumer Discretionary 11.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
126
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.09M 0.02%
30,896
-6,613
-18% -$206K
VTI icon
127
Vanguard Total Stock Market ETF
VTI
$655B
$1.08M 0.02%
5,570
-100
-2% -$18.3K
PM icon
128
Philip Morris
PM
$305B
$1.05M 0.02%
12,683
+1,169
+10% +$91K
SNA icon
129
Snap-on
SNA
$21.1B
$1.03M 0.02%
6,000
AXP icon
130
American Express
AXP
$229B
$1.02M 0.02%
8,453
+166
+2% +$18.4K
SABA
131
Saba Capital Income & Opportunities Fund II
SABA
$220M
$1.01M 0.02%
91,954
VIG icon
132
Vanguard Dividend Appreciation ETF
VIG
$112B
$1.01M 0.02%
7,160
BMY icon
133
Bristol-Myers Squibb
BMY
$128B
$1M 0.02%
16,170
-300
-2% -$18.4K
IBM icon
134
IBM
IBM
$204B
$955K 0.02%
7,932
+711
+10% +$82.2K
VFC icon
135
VF Corp
VFC
$6.72B
$936K 0.02%
10,960
-1,345
-11% -$107K
CVS icon
136
CVS Health
CVS
$137B
$921K 0.02%
13,489
+2,160
+19% +$140K
UTMD icon
137
Utah Medical Products
UTMD
$220M
$920K 0.02%
10,915
+765
+8% +$65.2K
K
138
DELISTED
Kellanova
K
$855K 0.02%
14,638
-799
-5% -$48K
LULU icon
139
lululemon athletica
LULU
$13.4B
$853K 0.02%
2,451
-19
-0.8% -$6.6K
ZTS icon
140
Zoetis
ZTS
$32.2B
$823K 0.01%
4,972
+38
+0.8% +$6.18K
XLV icon
141
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$795K 0.01%
7,010
DGX icon
142
Quest Diagnostics
DGX
$25.6B
$791K 0.01%
6,638
-19
-0.3% -$2.32K
VYM icon
143
Vanguard High Dividend Yield ETF
VYM
$81.3B
$774K 0.01%
+8,460
New +$735K
HASI icon
144
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$717K 0.01%
11,300
-300
-3% -$15.3K
LMNR icon
145
Limoneira
LMNR
$242M
$702K 0.01%
42,160
-3,375
-7% -$50.7K
BIV icon
146
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$697K 0.01%
7,505
-450
-6% -$41.9K
NAC icon
147
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$697K 0.01%
46,000
BBWI icon
148
Bath & Body Works
BBWI
$4.13B
$684K 0.01%
22,753
+532
+2% +$15.4K
NVR icon
149
NVR
NVR
$16.9B
$681K 0.01%
167
-1
-0.6% -$4.16K
CMI icon
150
Cummins
CMI
$91.3B
$659K 0.01%
2,900

Similar funds

Everett Harris & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Everett Harris & Co held 261 positions worth $5.66B, up 10% from $5.12B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Everett Harris & Co's Q4 2020 filing shows 15 new, 82 increased, 96 reduced and 8 closed positions. Its largest new stake was Vanguard High Dividend Yield ETF: 8,460 shares worth $774K. The largest sale was Unilever NV New York Registry Shares, an estimated $62.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Everett Harris & Co's largest Q4 2020 buy was Vanguard High Dividend Yield ETF: 8,460 shares worth $774K.
  • Everett Harris & Co added most to Unilever in Q4 2020, an estimated $63.6M increase.
  • Everett Harris & Co's biggest Q4 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $9.61M.
  • Everett Harris & Co fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $62.1M.
  • Everett Harris & Co's ten largest holdings make up 55% of its $5.66B portfolio in Q4 2020.
  • Everett Harris & Co opened 15 new positions and closed 8 in Q4 2020.
  • Everett Harris & Co's portfolio value rose 10% quarter-over-quarter to $5.66B.

Based on Everett Harris & Co's 13F filing for Q4 2020, filed 4 Feb 2021.